DK1143954T3 - Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller - Google Patents

Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller

Info

Publication number
DK1143954T3
DK1143954T3 DK99962960T DK99962960T DK1143954T3 DK 1143954 T3 DK1143954 T3 DK 1143954T3 DK 99962960 T DK99962960 T DK 99962960T DK 99962960 T DK99962960 T DK 99962960T DK 1143954 T3 DK1143954 T3 DK 1143954T3
Authority
DK
Denmark
Prior art keywords
treatment
acid derivatives
nicotinic acid
dna damage
skin cells
Prior art date
Application number
DK99962960T
Other languages
English (en)
Inventor
Elaine L Jacobson
Myron K Jacobson
Original Assignee
Univ Kentucky Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22333250&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK1143954(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Univ Kentucky Res Found filed Critical Univ Kentucky Res Found
Application granted granted Critical
Publication of DK1143954T3 publication Critical patent/DK1143954T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
    • A61K8/4926—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom having six membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A61K8/673—Vitamin B group
    • A61K8/675—Vitamin B3 or vitamin B3 active, e.g. nicotinamide, nicotinic acid, nicotinyl aldehyde
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Toxicology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Cosmetics (AREA)
DK99962960T 1998-12-01 1999-12-01 Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller DK1143954T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11048298P 1998-12-01 1998-12-01
EP99962960A EP1143954B1 (en) 1998-12-01 1999-12-01 Use of nicotinic acid derivatives for the treatment of dna damage in skin cells

Publications (1)

Publication Number Publication Date
DK1143954T3 true DK1143954T3 (da) 2004-12-20

Family

ID=22333250

Family Applications (1)

Application Number Title Priority Date Filing Date
DK99962960T DK1143954T3 (da) 1998-12-01 1999-12-01 Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller

Country Status (15)

Country Link
US (4) US6337065B1 (da)
EP (1) EP1143954B1 (da)
AR (1) AR023715A1 (da)
AT (1) ATE273008T1 (da)
AU (1) AU762770B2 (da)
CA (1) CA2352964C (da)
DE (1) DE69919403T2 (da)
DK (1) DK1143954T3 (da)
ES (1) ES2228146T3 (da)
HK (1) HK1041436B (da)
IL (2) IL143112A0 (da)
NZ (1) NZ511708A (da)
PT (1) PT1143954E (da)
TW (1) TWI257303B (da)
WO (1) WO2000032179A2 (da)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1143954T3 (da) * 1998-12-01 2004-12-20 Univ Kentucky Res Found Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller
US6673826B2 (en) 1999-07-23 2004-01-06 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US6864274B2 (en) 1999-07-23 2005-03-08 Alwyn Company, Inc. Allantoin-containing skin cream
US6896897B2 (en) 1999-07-23 2005-05-24 Alwyn Company, Inc. Flexible applicator for applying oil-in-water emulsion with improved stability
US6531500B2 (en) 1999-07-23 2003-03-11 Alwyn Company, Inc. Methods for treatment of inflammatory diseases
US20020054895A1 (en) 1999-07-23 2002-05-09 Alwyn Company, Inc. Allantoin-containing skin cream
MXPA02010184A (es) * 2000-04-14 2004-08-19 Niadyne Corp Formulaciones topicas para el suministro transdermico de niacina y metodos para tratar hiperlipidemia.
ES2274879T3 (es) * 2000-04-14 2007-06-01 Niadyne Corporation Metodo y composiciones utiles en el potenciamiento del suministro de oxigeno a las celulas.
US20020182585A1 (en) * 2001-01-10 2002-12-05 George Kindness Combination and method using EDTA, cystine, zinc and selenium for anti-thrombin effect and for anti-platelet aggregation and measurement of efficacy
CA2437844C (en) * 2001-03-08 2007-05-15 Elaine Jacobson Method for increasing leptin levels using nicotinic acid compounds
ITMI20011019A1 (it) * 2001-05-17 2002-11-17 Carlo Ghisalberti Sostanze furiliche per uso topico
AU2002950744A0 (en) * 2002-08-13 2002-09-12 Medihoney Pty Ltd Composition
US7326690B2 (en) * 2002-10-30 2008-02-05 Bach Pharma, Inc. Modulation of cell fates and activities by phthalazinediones
EP1572101A4 (en) * 2002-12-19 2008-04-09 Yitzchak Hillman TREATMENT OF DISEASES BY ANTIMICROBIAL PEPTIDES
JP5074661B2 (ja) * 2002-12-26 2012-11-14 味の素株式会社 肝癌発生・進展抑制剤
US20040161435A1 (en) * 2003-02-14 2004-08-19 Gupta Shyam K. Skin Firming Anti-Aging Cosmetic Mask Compositions
WO2004100990A1 (ja) 2003-05-19 2004-11-25 Genecare Research Institute Co., Ltd. 癌細胞に対するアポトーシス誘導剤
US8338648B2 (en) * 2004-06-12 2012-12-25 Signum Biosciences, Inc. Topical compositions and methods for epithelial-related conditions
US7615641B2 (en) * 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
CA2612235C (en) 2005-06-24 2013-10-22 Arizona Board Of Regents On Behalf Of The University Of Arizona Method for treating hair growth disorders, such as female pattern alopecia, and compositions useful therefor
WO2007136744A1 (en) * 2006-05-19 2007-11-29 The Johns Hopkins University Crystal structure of a substrate complex of nampt/pbef/visfatin
US20070293458A1 (en) * 2006-06-16 2007-12-20 Ip-6 Research Inc. Prevention of nuclear, solar, and other radiation-induced tissue damage
WO2008025755A1 (de) * 2006-09-01 2008-03-06 Basf Se Verwendung von n-haltigen heterozyklen in dermokosmetika
WO2008077616A1 (en) * 2006-12-22 2008-07-03 Csl Behring Gmbh Modified coagulation factors with prolonged in vivo half-life
US9642845B2 (en) * 2007-02-28 2017-05-09 University Of Kentucky Research Foundation Method for alleviating side effects of retinoic acid therapy and/or improving efficacy without interfering with efficacy
AU2009221634B2 (en) * 2008-03-03 2014-05-08 Nad Life Pty Ltd Pharmaceutical formulations of resveratrol and methods of use thereof for treating cell disorders
EP2168574A1 (en) 2008-09-25 2010-03-31 Noureddine Frid Compound for local deletion of tumors
US8173446B2 (en) 2009-12-21 2012-05-08 General Electric Company Method of producing an integrated micromagnet sensor assembly
US20140135372A1 (en) 2010-02-02 2014-05-15 Elliott Farber Compositions and methods of treatment of inflammatory skin conditions using allantoin
WO2012114204A2 (en) * 2011-02-15 2012-08-30 Ecole Polytechnique Federale De Lausanne (Epfl) Epfl-Tto Methods of treating mitochondrial dysfunction
RU2016149767A (ru) 2014-06-06 2018-07-16 Глэксосмитклайн Интеллекчуал Проперти (Но.2) Лимитед Аналоги никотинамидрибозида и фармацевтические композиции и их применение
WO2016178207A1 (en) * 2015-05-04 2016-11-10 Ramot At Tel-Aviv University Ltd. Methods and kits for fragmenting dna
US11344497B1 (en) 2017-12-08 2022-05-31 Quicksilver Scientific, Inc. Mitochondrial performance enhancement nanoemulsion
US10722465B1 (en) 2017-12-08 2020-07-28 Quicksilber Scientific, Inc. Transparent colloidal vitamin supplement
US11767314B2 (en) 2018-11-02 2023-09-26 Conopco, Inc. Bioenergetic nicotinic acid glycerol esters, compositions and methods of using same
US11291702B1 (en) 2019-04-15 2022-04-05 Quicksilver Scientific, Inc. Liver activation nanoemulsion, solid binding composition, and toxin excretion enhancement method

Family Cites Families (55)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185679A (en) 1965-05-25 Azepine derivatives
US3276960A (en) 1961-08-21 1966-10-04 Kendall & Co Analgesic methods and compositions
US4246285A (en) 1975-10-20 1981-01-20 The Procter & Gamble Company Skin conditioning compositions containing guanidine inorganic salts
HU184626B (en) 1979-06-01 1984-09-28 Ferrokemia Ipari Congesting cosmetics first of all hair-restorers
EP0057797B1 (en) 1981-02-03 1986-06-25 Imperial Chemical Industries Plc Process for the extraction of metal values and novel metal extractants
US4607101A (en) 1981-08-27 1986-08-19 Jaye-Boern Laboratories, Inc. Method of treating acne vulgaris with a composition containing carbamide peroxide
US5635497A (en) 1982-06-23 1997-06-03 Yamanouchi Europe B.V. Topical application compositions
US4459153A (en) 1982-09-20 1984-07-10 The United States Of America As Represented By The United States Department Of Energy Pyrochemical process for extracting plutonium from an electrolyte salt
US4474753A (en) 1983-05-16 1984-10-02 Merck & Co., Inc. Topical drug delivery system utilizing thermosetting gels
ATE82684T1 (de) 1984-03-07 1992-12-15 Roshdy Ismail Mittel zur behandlung und zum schutz der haut.
US4665192A (en) 1984-03-19 1987-05-12 The Rockefeller University 2-(2-furoyl)-4(5)-2(furanyl)-1H-imidazole
US4758583A (en) 1984-03-19 1988-07-19 The Rockefeller University Method and agents for inhibiting protein aging
DE3570598D1 (en) 1984-11-15 1989-07-06 Nitto Denko Corp Composition for percutaneous administration
US5053396A (en) * 1985-08-27 1991-10-01 Blass David H Therapeutic composition
DE3532562A1 (de) 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
LU86574A1 (fr) 1986-09-08 1988-04-05 Oreal Composition pour induire et stimuler la croissance des cheveux et freiner leur chute,a base d'esters nicotiniques et de derives de pyrimidine
GB2216003B (en) 1988-02-18 1992-06-10 Toyama Chemical Co Ltd Hair restorer
US4981681A (en) 1988-08-26 1991-01-01 Vittorio Tosti Lotion mixture and method of treating psoriasis
US5077313A (en) 1988-11-25 1991-12-31 Gert Lubec Process for inhibiting pathological collagen cross-linking in diabetes patients
US5133958A (en) 1989-04-20 1992-07-28 Erwin Stuckler Agent for nail, skin and hair care
US5129360A (en) 1990-01-24 1992-07-14 The United States Of America As Represented By The Secretary Of The Air Force Actively cooled effusion cell for chemical vapor deposition
GB9006785D0 (en) 1990-03-27 1990-05-23 Leung Lit Hung Composition and methods for treatment of acne vulgaris and retardation of ageing
US5114957A (en) 1990-05-08 1992-05-19 Biodor U.S. Holding Tocopherol-based antiviral agents and method of using same
US5043162A (en) 1990-09-05 1991-08-27 Trager Seymour F Hair growth promoter
FR2668366B1 (fr) 1990-10-30 1993-01-29 Oreal Utilisation cosmetique d'une composition ayant une activite antierythemale et composition correspondante.
GB9114346D0 (en) 1991-07-03 1991-08-21 Dow Corning Sa A method of accelerating drug permeation
US5358969A (en) 1991-12-16 1994-10-25 Washington University Method of inhibiting nitric oxide formation
US5240945A (en) 1992-02-18 1993-08-31 Warshaw Thelma G Method and compositions for treating acne
US5318960A (en) 1992-06-03 1994-06-07 Frank Toppo System for transdermal delivery of pain relieving substances
US5449688A (en) 1993-03-30 1995-09-12 The United States Of America As Represented By The Department Of Health And Human Services Method of treating chronic inflammatory diseases
US6231852B1 (en) * 1993-11-18 2001-05-15 The Regents Of The University Of California Method for reducing BCL-2 expressing cells resistance to death
FR2715565B1 (fr) 1994-01-31 1996-03-15 Oreal Composition cosmétique ou dermatologique stabilisée contenant plusieurs précurseurs d'un même actif pour maximaliser sa libération, son utilisation.
GB9404485D0 (en) 1994-03-09 1994-04-20 Cancer Res Campaign Tech Benzamide analogues
US6174890B1 (en) * 1994-06-02 2001-01-16 Dan Riga Anti-stress, anti-impairment and anti-aging drug and process for manufacturing thereof
US5612382A (en) 1994-07-15 1997-03-18 Frances B. Fike Composition for percutaneous absorption of pharmaceutically active ingredients
US5496827A (en) * 1994-07-15 1996-03-05 Patrick; Jay Compositions for the transdermal delivery of nutrients
DE4433130C2 (de) 1994-09-16 1997-02-06 Deutsches Krebsforsch Poly(ADP-Ribose)-Polymerase überexprimierende tierische Zellinien und Verfahren zur Identifizierung von DNA-schädigenden Substanzen
US5690944A (en) 1994-12-20 1997-11-25 Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. Cosmetic compositions containing lactate dehydrogenase inhibitors
EP0717984B1 (en) 1994-12-20 2004-11-03 Unilever Plc Lactate dehydrogenase inhibitors in cosmetic compositions
EP0814812A1 (en) * 1995-03-14 1998-01-07 Edward G. Shaskan Compositions comprising nicotynylalanine and an inhibitor of glycine conjugation or vitamin b6
JP4553166B2 (ja) 1995-05-01 2010-09-29 スカリスタ リミテッド ニコチン酸エステルおよびそれを含む薬剤組成物
JPH08301760A (ja) 1995-05-10 1996-11-19 Shiseido Co Ltd 皮膚外用剤
US5571794A (en) 1995-06-22 1996-11-05 Frome; Bruce M. Non-invasive novel method fo cosmetic lip augmentation
JP3542665B2 (ja) 1995-07-07 2004-07-14 株式会社資生堂 抗老化皮膚外用剤、コラーゲン架橋阻害皮膚外用剤及び抗紫外線皮膚外用剤
ES2238695T3 (es) * 1995-08-14 2005-09-01 Optigenex, Inc. Composiciones de carotenoide-nicotinamida-zinc y metodos de tratamiento usando las mismas.
US5939082A (en) * 1995-11-06 1999-08-17 The Procter & Gamble Company Methods of regulating skin appearance with vitamin B3 compound
US6071888A (en) * 1996-01-24 2000-06-06 Aliatros Medical, A.S. Composition for treating cancer
US5736529A (en) * 1996-03-22 1998-04-07 Neurocal International Inc. Use of NAD-related compounds in the treatment of neural trauma to inhibit neurodegeneration
AUPN892496A0 (en) * 1996-03-25 1996-04-18 Technical Consultancy Services Pty Limited Acne treatment
US5693671A (en) * 1996-05-01 1997-12-02 Harbor-Ucla Research And Education Institute L-glutamine therapy for sickle cell diseases and thalassemia
CA2323179A1 (en) * 1998-03-16 1999-09-23 The Procter & Gamble Company Method of reducing cellulite in mammalian skin
US6277613B1 (en) 1998-06-10 2001-08-21 The Rockefeller University TRF1 binding protein, methods of use thereof
US6149924A (en) * 1998-07-20 2000-11-21 Biomed Research & Technologies, Inc. Composition for enhancing lipid production, barrier function, hydrogen peroxide neutralization, and moisturization of the skin
US5976513A (en) 1998-10-16 1999-11-02 The Procter & Gamble Company UV protection compositions
DK1143954T3 (da) * 1998-12-01 2004-12-20 Univ Kentucky Res Found Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller

Also Published As

Publication number Publication date
IL143112A0 (en) 2002-04-21
US6337065B1 (en) 2002-01-08
CA2352964A1 (en) 2000-06-08
US6552050B2 (en) 2003-04-22
US7425319B2 (en) 2008-09-16
IL143112A (en) 2006-10-31
AU762770B2 (en) 2003-07-03
US20040147491A1 (en) 2004-07-29
DE69919403T2 (de) 2005-09-08
AR023715A1 (es) 2002-09-04
WO2000032179A2 (en) 2000-06-08
US20010033848A1 (en) 2001-10-25
ATE273008T1 (de) 2004-08-15
TWI257303B (en) 2006-07-01
WO2000032179A3 (en) 2001-12-13
NZ511708A (en) 2003-12-19
EP1143954A2 (en) 2001-10-17
HK1041436B (zh) 2005-03-11
EP1143954B1 (en) 2004-08-11
PT1143954E (pt) 2004-12-31
CA2352964C (en) 2006-10-17
AU1929200A (en) 2000-06-19
HK1041436A1 (en) 2002-07-12
DE69919403D1 (de) 2004-09-16
ES2228146T3 (es) 2005-04-01
US6403619B1 (en) 2002-06-11

Similar Documents

Publication Publication Date Title
DK1143954T3 (da) Anvendelse af nicotinsyrederivater til behandling af DNA-skade i hudceller
EE200100480A (et) Ksenoon kasutamiseks närvimürgistuste ravis
DE69933283D1 (de) Photoaktivierbare nukleinsäure-derivate
DE1051515T1 (de) Modifizierte nuklein-säure sonden und dessen verwendungen
DK1173441T3 (da) 6-alkenyl-, 6-alkynyl- og 6-epoxy-epothilon-derivater, fremgangsmåde til fremstilling af disse samt deres anvendelse i farmaceutiske sammensætninger
DK0948308T3 (da) Fremgangsmåder til behandling af hudpigmentering
DE60008527D1 (de) Zellproliferation inhibitoren
DK1228032T3 (da) Præparater, som indeholder hydroxyicosatetraensyrederivater, og fremgangsmåder til anvendelse ved behandling af öjentörhedslidelser
ATE272998T1 (de) Hautreinigungszusammensetzung mit verbesserter stabilität
EP1185555A4 (en) COMPOSITIONS ISOLATED FROM SKIN CELLS AND METHODS FOR THEIR USE
DE60008807D1 (de) Binaphtol-monophosphorsäurederivate und deren Verwendung
DE69925882D1 (de) Aminosäurederivate als Entzündungshemmende Mittel
ID22841A (id) Penggunaan larutan-larutan asam manonatrium iminodiasetat di dalam pembuatan asam n-fosfonometiliminodiasetat
ITMI20001555A0 (it) Procedimento e dispositivo di trattamento elettrochimico
NO20014848D0 (no) Fremgangsmåte for anvendelse av Emamectin ved behandling av fiskeparasitter
DE50008571D1 (de) Verfahren zur Herstellung von Lithiumkomplexsalzen zur Anwendung in elektrochemischen Zellen
DK1073673T3 (da) Hidtil ukendte octahydro-6, 10-dioxo-6H-pyridazino [1,2-a] [1,2] - diazepin-1-carboxylsyre-derivater, fremgangsmåde til deres fremstilling og deres anvendelse til fremstilling af terapeutisk aktive forbindelser
NO20012541D0 (no) Anvendelse av fosfonomaursyrederivater for behandling av infeksjoner
NO994386D0 (no) 2-substituerte benzoylcykloalkyl-1-karboksylsyrederivater
ITMI991895A0 (it) Depigmentanti cutanei
EE200200353A (et) Inimese heparanaasisarnane polüpeptiid ja nukleiinhape
DK1036319T3 (da) Fremgangsmåde til opnåelse af L-dihydroorotsyre og anvendelse deraf
NO20015731D0 (no) Anvendelse av PIT-emulsjoner i fermenteringsprosesser
ATE227288T1 (de) Acetylenische ortho-sulfonamido- und phosphinsäure-amido-bicyclische heteroarylhydroxamsäure als tace-inhibitoren
DE69934336D1 (de) Verwendung von halofuginone zur behandlung von urethralstriktur